Physician profile
Stephen E Mueller
NPI 1669692802
$529.75
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.18 · 2020: $329 · 2021: $173 · 2022: $9.54.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $236.08 | 2020-2021 | |
| Glaxosmithkline, LLC. | $137.47 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.34 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $23.30 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $21.23 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $20.61 | 2020 | |
| Vericel Corporation | $18.18 | 2019 | |
| Itamar Medical INC | $9.54 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Mueller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.